Clinical Product Validation and Regulatory Pathways

Clinical product validation and regulatory pathways in biotechnology development

Clinical product validation represents a defining phase in biotechnology development, determining whether an investigational therapy demonstrates sufficient safety, efficacy, and quality to advance toward regulatory approval. In the United States, this validation process operates within a highly structured regulatory framework designed to ensure that innovative therapies entering the healthcare system meet rigorous scientific and manufacturing … Read more